سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review

Publish Year: 1396
Type: Journal paper
Language: English
View: 119

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دانلود نمایند.

Export:

Link to this Paper:

Document National Code:

JR_JHGG-2-2_005

Index date: 21 August 2022

Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review abstract

In the last two decades, stem cell therapy has been developed rapidly. Stem cells have now emerged as a new treatment for manymajor disorders including neurodegenerative diseases such multiple sclerosis (MS). Recently, the attention of researchers workingonMShave been attracted to cell therapy using therapeutic stem cells (TSCs). In this brief narrative reviewweexplore the applicationof TSCs in last 5 years registered clinical trials. At the end, we will discuss the challenges and hopes ahead of therapeutic stem cellsin treating MS patients.

Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review Keywords:

Therapeutic Stem Cells and Their Utilization in Multiple Sclerosis Clinical Trials: A Mini Review authors

Saman Esmaeilnejad

Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Samaneh Dehghan

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

Mohammad Javan

Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran